Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oncology Institute Inc | TOIIW | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.23 | 08:30:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.23 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.022 - 0.3699 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.23 | USD |
Oncology Institute Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 809.76M | 73.75M | - | 324.24M | -83.07M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Oncology Institute News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TOIIW Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.2475 | 0.2475 | 0.2255 | 0.2299555 | 51 | -0.0175 | -7.07% |
| 1 Month | 0.2135 | 0.2475 | 0.155 | 0.2004693 | 9,972 | 0.0165 | 7.73% |
| 3 Months | 0.240101 | 0.3699 | 0.155 | 0.2362717 | 8,396 | -0.0101 | -4.21% |
| 6 Months | 0.1264 | 0.3699 | 0.1188 | 0.2207999 | 6,016 | 0.1036 | 81.96% |
| 1 Year | 0.0532 | 0.3699 | 0.022 | 0.0960939 | 11,166 | 0.1768 | 332.33% |
| 3 Years | 1.775 | 1.775 | 0.022 | 0.5474526 | 17,636 | -1.55 | -87.04% |
| 5 Years | 1.775 | 1.775 | 0.022 | 0.5474526 | 17,636 | -1.55 | -87.04% |
Oncology Institute Description
| The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |
